Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

MiR-939-5p, tumor suppressor and potential therapeutic target in TNBC

March 4, 2021

Wellmarker Bio receives phase I study approval for WM-S1-030 in Australia

March 4, 2021

Ankh Life Sciences describes new anticancer compounds

March 4, 2021

Cancer-associated fibroblasts influence GIST progression and metastasis through PDGFC secretion

March 4, 2021

At ESMO TAT meeting, translating translation inhibition

March 3, 2021

Poziotinib twice daily effective in patients with EGFR/HER2 exon 20-mutant NSCLC

March 3, 2021

Phase I data reported for CC-90010 in patients with solid tumors

March 3, 2021

Applied Pharmaceutical Science identifies new RET inhibitors

March 3, 2021

First-in-human data presented for SCC-244 in NSCLC

March 3, 2021

AbbVie initiates first-in-human study of ABBV-637 as monotherapy or in combination

March 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...